B.C. announces universal coverage for medication to treat opioid addiction
British Columbia says it’s the first in Canada to provide universal coverage for eligible medications used for the treatment of opioid-use disorder.
Source: CBC | Health - June 14, 2023 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Adolescent Residential Addiction Facilities Largely Do Not Provide Buprenorphine
WEDNESDAY, June 14, 2023 -- Only one in four U.S. facilities offer buprenorphine for adolescent residential addiction treatment, according to a research letter published in the June 13 issue of the Journal of the American Medical...
Source: Drugs.com - Pharma News - June 14, 2023 Category: Pharmaceuticals Source Type: news

Could Weight Loss Drug Treat Addiction as Well as Obesity?
In addition to suppressing appetite, in some people, glucagon-like peptide-1 (GLP-1) agonists like semaglutide may curb cravings for alcohol or cigarettes, according to reports not yet backed up by research.
Source: WebMD Health - June 13, 2023 Category: Consumer Health News Source Type: news

Few Rehab Centers for Teens Offer Recommended Medicine
Only 1 in 4 residential treatment centers for teens offers a recommended medicine for opioid addiction, according to a study that exposes an important gap in care. Posing as an aunt or uncle seeking help for a fictitious 16-year-old who survived a fentanyl overdose, researchers called U.S. rehabs and asked if they offered the treatment medication buprenorphine. Of 160 facilities with care for teens, just 39 provided buprenorphine, also known by the brand name Suboxone. One hundred said they didn’t and 21 said they didn’t know. “As somebody who’s tried to promote the use of evidence-based treatments ...
Source: TIME: Health - June 13, 2023 Category: Consumer Health News Authors: Carla K. Johnson/AP Tags: Uncategorized Addiction healthscienceclimate wire Source Type: news

OHSU: Teens seldom given opioid addiction meds in treatment centers
Despite a surge in illegal fentanyl use among youth, adolescent treatment centers are reluctant to use buprenorphine to treat opioid use disorder, according to a study out published Tuesday by researchers at OHSU.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - June 13, 2023 Category: Pharmaceuticals Authors: Elizabeth Hayes Source Type: news

Could Semaglutide Treat Addiction as Well as Obesity? Could Semaglutide Treat Addiction as Well as Obesity?
In addition to suppressing appetite, in some people, GLP-1 agonists such as semaglutide may curb cravings for alcohol or cigarettes, according to anecdotal reports.Medscape Medical News
Source: Medscape Psychiatry Headlines - June 13, 2023 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news

Teens Rarely Get Anti-Addiction Meds When Treated for Opioid Misuse
TUESDAY, June 13, 2023 -- The medication buprenorphine normalizes brain function in people addicted to opioids, but teens rarely receive it at U.S. treatment centers, a new study finds. Only one in four adolescent residential treatment centers in...
Source: Drugs.com - Daily MedNews - June 13, 2023 Category: General Medicine Source Type: news

Few rehab centers for addicted teens offer recommended medicine, US study finds
A new study finds only 1 in 4 residential treatment centers for U.S. teens offers a recommended treatment medicine for opioid addiction
Source: ABC News: Health - June 13, 2023 Category: Consumer Health News Tags: Health Source Type: news

2018 to 2021 Saw Rise of Non-LSD Hallucinogen Use in U.S. Young Adults
TUESDAY, June 13, 2023 -- Past-year use of non-lysergic acid diethylamide (LSD) hallucinogens was twice as high in 2021 as in 2018 among U.S. young adults, according to a study published online June 7 in Addiction. Katherine M. Keyes, Ph.D.,...
Source: Drugs.com - Pharma News - June 13, 2023 Category: Pharmaceuticals Source Type: news

Most U.S. Drug Treatment Centers Don ’t Give Teens Addiction Medication, Study Says
Only one in four adolescent residential treatment centers in the U.S. are using medication to treat opioid use disorder in adolescents, a study out Tuesday found.
Source: Forbes.com Healthcare News - June 13, 2023 Category: Pharmaceuticals Authors: Ana Faguy, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news topline Source Type: news

Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder
NIH-funded study indicates substantial need to expand access to evidence-based treatment among young people
Source: NIDA News - June 13, 2023 Category: Addiction Tags: Addiction Science, Buprenorphine, Children & Teens, College-Age and Young Adults, Evidence-Based Practices, Overdose, Parents, Pre-Teens, Students, Teachers and Educators, Teens, Treatment, Young Adults, Public Health, Treatment, News Release Source Type: news

Walgreens Reaches Deal With New Mexico Over Opioid Crisis Walgreens Reaches Deal With New Mexico Over Opioid Crisis
Walgreens Boots Alliance has agreed to pay $500 million to New Mexico to settle claims that its pharmacies helped fuel opioid addiction in the state by failing to stop illegal pill sales, lawyers for the state announced on Friday.Reuters Health Information
Source: Medscape Medical News Headlines - June 12, 2023 Category: Consumer Health News Tags: Psychiatry News Source Type: news

Recovering From Drug Addiction Was Hard. Tranq Made it Worse
PHILADELPHIA—David “Lee” Wells marveled at how it felt to hold an iced coffee in his hand again after losing his fingers to “tranq” wounds that rotted away his flesh.#philadelphia #davidleewells
Source: Reuters: Health - June 11, 2023 Category: Consumer Health News Source Type: news

Governments get nearly $19 billion more in opioid lawsuit settlements
States and local governments will receive an additional $18.75 billion from pharmacy chains and drug manufacturers to settle lawsuits over their roles in flooding the country with painkillers — money meant to help communities still grappling with an unparalleled addiction and overdose crisis,…#allergan #teva #cvs #walmart #johnsonjohnson #amerisourcebergen #mexico #newmexico #albertsons #kroger
Source: Reuters: Health - June 10, 2023 Category: Consumer Health News Source Type: news

Shroom bloom: Psychedelic drug use among American under-30s doubles in just three years
A study published Wednesday in the journal Addiction found that psychedelic use in people under 30 doubled between 2018 and 2021. Rates increased from 3.4 percent to 6.4 percent.
Source: the Mail online | Health - June 9, 2023 Category: Consumer Health News Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20